Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics · Familial Nonmedullary Thyroid Cancer

Protecting Your Family: Screening and Genetic Counseling

At a Glance

Routine ultrasound is not automatically needed for every relative with familial thyroid cancer. Genetic counseling can identify syndromes that require screening, while families without a known syndrome should balance family history against benign nodules, biopsies, and surgery.

When thyroid cancer runs in the family, the most pressing question for many is: “Do my children and siblings need to be tested?” While it may seem like more information is always better, the decision to screen asymptomatic (symptom-free) relatives is complex and not universally recommended for every non-syndromic family [1][2].

The Role of Genetic Counseling First

Before starting any screening, a highly actionable first step is often genetic counseling. A counselor will build a “pedigree” (a detailed family tree) to look for signs that your family might have a syndromic form of thyroid cancer [3].

  • Why it matters: In a minority of families, thyroid cancer is part of a broader syndrome like Cowden syndrome or FAP [3][4]. These syndromes have clear genetic tests and require specific screening not just for the thyroid, but also for the colon, breasts, or kidneys [5][6]. In these cases, pediatric screening is often standard.
  • Non-Syndromic Families: For the majority of families, there is no single “yes or no” genetic test available today [7][3]. In these cases, the decision to screen is based entirely on your clinical family history. To prepare, collect the pathology reports and exact ages of diagnosis for all affected members.

Evaluating the Family History

Doctors distinguish between families with two affected relatives and those with three or more, as the clinical suspicion changes.

  • Families with 2 affected relatives: The risk to other family members appears to be lower. Because of the risk of finding harmless nodules, routine ultrasound screening is often not recommended for asymptomatic relatives in these families, especially for children [8].
  • Families with 3 or more affected relatives: This is a stronger indicator of a hereditary link. In these larger kindreds, doctors are more likely to consider ultrasound screening [9]. In one specific research study of selected families, cancer was detected in 22.7% of relatives with three or more affected members, versus 4.6% in families with two [10]. Note: These are study-specific estimates from a particular group, not a universal absolute risk for your child.

Understanding the Risks of Screening

It may be surprising to learn that screening has potential harms. The goal of screening is to find cancer early, but it also frequently finds “incidentalomas”—harmless nodules that would never have caused a problem [10][11].

  • Overdiagnosis: Ultrasound is so sensitive that it finds benign (non-cancerous) nodules in up to 44% of relatives [11]. This can lead to “scan anxiety” and a cycle of repeated ultrasounds [12][13].
  • Overtreatment: Finding a nodule may lead to a Fine Needle Aspiration (FNA) biopsy based on its size and appearance [8][11]. If the biopsy is “indeterminate” (unclear), it may be managed with repeat FNA, molecular testing, or diagnostic surgery to remove part of the thyroid. In some cases, people undergo surgery for a tumor that was indolent (slow-growing) or entirely benign [10].
  • Specific Caution for Children: Research suggests that routine screening is generally not necessary for children and adolescents if only one parent is affected by non-syndromic FNMTC, as the risk of finding a significant cancer is very low compared to the risk of unnecessary procedures [8].

When is Screening Worth It?

If your family has three or more affected members, screening might be considered because screen-detected cancers in these families tend to be smaller and may require less extensive surgery and less radioactive iodine [10].

However, there is no universally endorsed starting age or interval for non-syndromic FNMTC. Some experts suggest considering a baseline ultrasound in early adulthood for high-risk families, but this must be balanced against the risk of finding harmless nodules [14][10]. Choosing not to do routine ultrasound is not the same as ignoring symptoms; relatives should still have regular clinical neck exams by their primary care doctor. Ultimately, the choice should be a shared decision between your family and a thyroid specialist, focusing on your family’s specific history.

Common questions in this guide

Does every family with thyroid cancer need ultrasound screening for relatives?
No. In non-syndromic families with only two affected relatives, routine ultrasound, especially for children, is often not recommended because it can find harmless nodules and lead to unnecessary procedures. Families with three or more affected relatives or a known syndrome may discuss screening with a thyroid specialist.
Why should genetic counseling come before screening family members?
A genetic counselor reviews the family tree, ages at diagnosis, and pathology reports to look for an inherited syndrome. If Cowden syndrome or familial adenomatous polyposis is suspected, genetic testing and screening of the thyroid and other organs may be recommended. Most non-syndromic families do not have one definitive genetic test, so decisions rely on family history.
What does having three or more relatives with thyroid cancer mean for screening?
Three or more affected relatives suggest a stronger hereditary pattern than two and may make ultrasound screening worth considering. This does not guarantee that a relative has cancer, and there is no universally accepted starting age or interval for non-syndromic families. A thyroid specialist can tailor the plan to the family history.
What are the downsides of a screening thyroid ultrasound?
Ultrasound can find small benign nodules that would never cause symptoms. These findings may lead to repeat scans, a needle biopsy, additional testing, or diagnostic surgery, especially when results are unclear. The possible benefit of earlier detection should be weighed against anxiety and unnecessary procedures.
When might a child in a family with thyroid cancer start screening?
There is no universally agreed starting age for screening in non-syndromic familial thyroid cancer. If several relatives are affected or a hereditary syndrome is identified, a specialist may recommend screening, sometimes during childhood for syndromic disease or with a baseline ultrasound in early adulthood for selected high-risk families. Regular clinical neck exams remain important even when routine ultrasound is not chosen.
What family details should I bring to genetic counseling?
Bring pathology reports, the exact ages at diagnosis, and the number of affected relatives. Also mention macrocephaly, unusual skin bumps, or early colon polyps because these findings may point to a syndrome that changes screening. The counselor can use this information to build a detailed family tree.

Get notified when new evidence is published on Familial papillary or follicular thyroid carcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

    Haugen BR, Alexander EK, Bible KC, et al.

    Thyroid : official journal of the American Thyroid Association 2016; (26(1)):1-133 doi:10.1089/thy.2015.0020.

    PMID: 26462967
  2. 2

    Familial non-medullary thyroid cancer: a critical review.

    Capezzone M, Robenshtok E, Cantara S, Castagna MG

    Journal of endocrinological investigation 2021; (44(5)):943-950 doi:10.1007/s40618-020-01435-x.

    PMID: 33025555
  3. 3

    Familial non-medullary thyroid cancer: unraveling the genetic maze.

    Peiling Yang S, Ngeow J

    Endocrine-related cancer 2016; (23(12)):R577-R595 doi:10.1530/ERC-16-0067.

    PMID: 27807061
  4. 4

    Recognizing Familial Thyroid Neoplasia: The Pathologist's Role in Diagnosis and Management.

    Nosé V, Canberk S, Baloch Z

    Advances in anatomic pathology 2026; (33(4)):291-303 doi:10.1097/PAP.0000000000000543.

    PMID: 42319956
  5. 5

    [Thyroid cancer in a child with Cowden syndrome].

    Bricheva EB, Nagaeva EV, Brovin DN, et al.

    Problemy endokrinologii 2024; (70(5)):84-90 doi:10.14341/probl13445.

    PMID: 39509640
  6. 6

    [Hereditary predispositions to follicular thyroid tumors].

    Decaussin-Petrucci M

    Annales de pathologie 2020; (40(2)):142-147 doi:10.1016/j.annpat.2020.02.011.

    PMID: 32192806
  7. 7

    Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors.

    Cirello V

    Minerva endocrinology 2021; (46(1)):5-20 doi:10.23736/S2724-6507.20.03338-6.

    PMID: 33045820
  8. 8

    Ultrasonography screening in children and adolescents who have one parent with familial non-medullary thyroid carcinoma.

    Rosario PW, Mourão GF

    Journal of paediatrics and child health 2022; (58(12)):2254-2257 doi:10.1111/jpc.16215.

    PMID: 36124950
  9. 9

    The impact of family history on non-medullary thyroid cancer.

    Nixon IJ, Suárez C, Simo R, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2016; (42(10)):1455-63.

    PMID: 27561845
  10. 10

    Results of Screening in Familial Non-Medullary Thyroid Cancer.

    Klubo-Gwiezdzinska J, Yang L, Merkel R, et al.

    Thyroid : official journal of the American Thyroid Association 2017; (27(8)):1017-1024 doi:10.1089/thy.2016.0668.

    PMID: 28657510
  11. 11

    Family Screening in Familial Papillary Carcinoma: The Early Detection of Thyroid Disease.

    Ríos A, Rodríguez JM, Navas D, et al.

    Annals of surgical oncology 2016; (23(8)):2564-70 doi:10.1245/s10434-016-5149-8.

    PMID: 27020589
  12. 12

    Papillary Thyroid Cancer Affecting Multiple Family Members: A Case Report and Literature Review of Familial Nonmedullary Thyroid Cancer.

    Baagar KA, Alowainati BI

    Case reports in endocrinology 2021; (2021()):3472000 doi:10.1155/2021/3472000.

    PMID: 34691791
  13. 13

    Surveillance-Associated Anxiety After Curative-Intent Cancer Surgery: A Systematic Review.

    Khatri R, Quinn PL, Wells-Di Gregorio S, et al.

    Annals of surgical oncology 2025; (32(1)):47-62 doi:10.1245/s10434-024-16287-5.

    PMID: 39343818
  14. 14

    Genetic endocrine tumors focusing on the thyroid.

    Ginzberg SP, Weller JHD, Skefos CM, Perrier ND

    Best practice & research. Clinical endocrinology & metabolism 2026; 102158 doi:10.1016/j.beem.2026.102158.

    PMID: 42632770

This page is for informational purposes only and does not constitute medical advice. A genetic counselor and thyroid specialist can help your family weigh screening benefits and harms based on its specific history.